IndraLab

Statements

EC 3.5.1.98 (histone deacetylase) inhibitor inhibits STAT1. 3 / 3
| 3
reach
"Likewise, treatment with the HDAC inhibitor trichostatin A potently inhibited ISGF3 transcriptional activity (Figure 6I), but no effect was observed for H2A.Z in ChIP assay (Figure 6J), ruling out class I and II HDACs in this process."
30240626
reach
"HDACi exposure of primary blood cells fails to induce caspase activation and STAT1 reduction."
24810717
reach
"HDACi prevent the removal of acetyl groups from lysine residues by histone deacetylases (HDACs), increase STAT1 acetylation and inhibit STAT1 signaling [25]."
22425562